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A specific prediction of our detailed cis-regulatory analysis of the Strongylocentrotus purpuratus (Sp) endo16 gene was that the later
expression of this gene would be driven by a midgut-specific transcriptional regulator. We have now identified this factor and determined some
of its functions. The cDNA sequence reveals it to be a POU domain factor related closely to the mammalian factors Brain-1, -2, and -4. The
factor was termed SpBrn1/2/4 (henceforth Brn1/2/4). Quantitative measurements of transcript prevalence show that the gene is first activated
in the 20-h blastula, but there remain only about 100 molecules of brn1/2/4 mRNA per embryo (only a few per endoderm cell) until an abrupt
10-fold increase occurs as gastrulation begins. Measured in the same embryos, the late rise in prevalence of endo16 transcripts follows that of
brn1/2/4 transcripts. As predicted by the endo16 model, brn1/2/4 expression is confined perfectly to the midgut, coincident with the domain
of endo16 expression. The kinetics of accumulation of these transcripts indicates that the switch into the late phase of endo16 expression
occurs when the brn1/2/4 transcript level nears its plateau (2000 molecules mRNA per embryo), after which each endo16 gene produces about
1 mRNA every 2 min (about 380 molecules mRNA per min in the whole embryo). Arrest of Brn1/2/4 translation by MASO treatment blocks
the late phase of endo16 expression and specifically abolishes expression of cis-regulatory Module B of endo16, while not affecting Module
A, also as predicted. The brn1/2/4 gene lies downstream of the regulatory genes executing post-gastrular specification of the midgut, as shown
by further gene expression perturbation experiments which provide an initial glimpse of the underlying network architecture.
D 2005 Elsevier Inc. All rights reserved.Introduction
The cis-regulatory apparatus of the sea urchin (Strong-
ylocentrotus purpuratus) endo16 gene is among the most
thoroughly understood of any developmental gene control
system. Functional studies have revealed the modular
organization of this system, and the regulatory significance
of every one of the 13 species of specific DNA target sites in
its most important cis-regulatory domains, Modules A and
B (Yuh and Davidson, 1996; Yuh et al., 1994, 1996, 1998,
2001; reviewed by Davidson, 2001). The outcome was a
predictive logic processing model, many aspects of which
have been experimentally tested (Yuh et al., 2001, op. cit.).0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.02.034
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Zhunan Town, Miaoli County 350, Taiwan, ROC.Here, we bring closure to a major feature of the model, the
predictions of which it was not possible to test directly until
an unknown regulatory input into the endo16 control system
could be identified and its expression explored. This paper
concerns the expression and the roles of the factor that
encodes this input. The discovery of its identity illuminates
both the developmental control of endo16 , and the
postgastrular gene regulatory network (GRN) of which
endo16 represents a peripheral terminus.
The endo16 gene encodes a secreted glycoprotein of the
embryo and larval midgut (Nocente-McGrath et al., 1989;
Soltysik-Espanola et al., 1994). The endo16 gene is
expressed initially in blastula stage embryos in all cells of
the veg2 lineage, that is, in cells that will contribute most of
the midgut, foregut, and the non-skeletogenic mesoderm of
the completed embryo, but it is silent in skeletogenic
mesenchyme and in all ectoderm cells (Ransick et al., 1993).
Following gastrulation, endo16 is expressed throughout the281 (2005) 286–298
C.-H. Yuh et al. / Developmental Biology 281 (2005) 286–298 287archenteron. This expression is shortly extinguished in the
foregut and then hindgut, however, continuing exclusively in
the midgut. After 48 h, the tripartite specification of these gutFig. 1. Summary of endo16 regulation, and the predicted role of the bUIQ transcri
expression constructs that include Modules B and A, reproduced from Yuh et al. (1
in (B–D). The construct drives a chloramphenicol acetyl transferase (CAT) reporte
harvested at various times (h) after fertilization and injection of the construct DNA
A–G of the complete endo16 cis-regulatory system (cf. Yuh and Davidson, 1996; Y
by numerals in red, in the three phases of the time course. (B) Initial activation pha
transcription factor binding at a target site in Module A (Yuh et al., 1998). (2) Exp
F–DC, which interact with a known element of Module A and shut down its activi
The bhumpQ phase of time course (~24–60 h): (3) Expression is driven by two Mod
soon as input from UI reaches a (low) threshold level, an internal repression functio
spatial repressors of Modules F–DC is no longer needed. (5) Function of Module
input linearly, and transfers the consequent regulatory output to the basal transcript
the changing activities of the Module B driver inputs (Yuh et al., 1998, 2001). (D) F
confined to transfer and amplification of Module B input; the Otx input into Modu
Module B during the hump phase is therefore not further required. (8) Input into M
driver (Yuh et al., 2001). Therefore, expression of UI itself must describe a rising
kinetics; and UI must be spatially confined to the midgut of the embryo, since thregions becomes definitive, and from 60 h onward, as the
onset of feeding capability approaches, endo16 continues to
be transcribed in the midgut of the pluteus stage embryo, everption factor. (A) The reproducible output time-course generated by endo16
998). The time-course is divided into the three phases considered separately
r, and output was measured as CAT enzyme activity in batches of embryos
into eggs. At right is a list of the qualitative functions executed by Modules
uh et al., 1996). (B–D) Internal regulatory functions, indicated individually
se (~18–24 h): (1) Expression is driven by widespread early embryonic Otx
ression is confined to veg2 cells by action of repressors binding in Modules
ty elsewhere in the embryo (Yuh and Davidson, 1996; Yuh et al., 2001). (C)
ule B activators, viz. UI and to a lesser extent CB2 (Yuh et al., 2001). (4) As
n blocks any input from the Otx factor into Module A, so the activity of the
A is now to receive the input from Module B (6). Module A amplifies this
ion apparatus, so that the overall transcriptional output directly reflects only
inal phase of rising midgut-specific output (N60 h): (7) Role of Module A is
le A is no longer available, and the internal repression function executed by
odule B is provided exclusively by UI, which from now onward is the sole
time course prior to 60 h in order to account for the late endo16 expression
at is where endo16 is expressed.
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time course of endo16 expression constructs is reproduced in
Fig. 1A, where shown are the output kinetics generated by
gene transfer vectors that contain either the complete endo16
cis-regulatory system or a B–A construct (i.e.,Modules B and
A linked to one another, as in the natural genomic context).
The schemas of Figs. 1B–D very briefly summarize the cis-
regulatory logic circuitry by which the successive spatial and
temporal phases of endo16 gene expression are controlled
(Yuh et al., 1998, 2001).
There are essentially three phases of expression, and of
the underlying control logic. At the outset (Fig. 1B),
expression is driven by a form of the ubiquitous transcrip-
tional activator Otx, but in order to confine expression to the
veg2 lineage, there is a required complex array of target
sites for dominant repressors and ancillary factors, located in
Modules F–C. The repression system works through a site
in Module A adjacent to the Otx binding site, and its overall
effect is to prevent Otx from activating the gene in
skeletogenic or ectoderm cells. During the 24- to 60-h
period, the second phase (or bhumpQ phase; Fig. 1C), control
is shifted to Module B, by activation of an internal
bintermodule switchQ that is thrown when the main driver
factor animating Module B appears in the embryo. In our
published models, this driver factor was referred to as bUIQ
(bUnique Factor IQ). The intermodule switch blocks Otx
input into the endo16 cis-regulatory system, though that
factor for a while remains present in the embryo. The
consequence of the activation of the switch is that now
Module B instead of Module A provides the positive input
into the basal transcription apparatus. However, the parti-
cipation of Module A is still required. Module A is func-
tionally linked to Module B in such a way as to amplify the
activity of the latter by a factor of about 4. After 60 h, the
third phase begins, and the situation changes dramatically
(Fig. 1D): there now begins a strong increase in endo16
expression driven exclusively by UI; and the internal switch
is no longer needed, since Otx activity in the relevant
domain of the embryo has disappeared. Thus, if the target
site that mediates the switch function is destroyed, the
output during the hump phase is enhanced because Otx and
UI inputs are summed, but there is no effect of this mutation
whatsoever after 60 h (Yuh et al., 2001).
The main significance of the shift in control from Module
A and its Otx-driven activation system of the initial phase to
Module B control and the UI-driven systems of the second
and third phases is that a spatial repression system is no
longer required to determine the boundaries of expression
once the Otx input is no longer operative. We know this
because later in development, constructs that lack all the
upstream spatial repression modules are still transcribed
accurately in the gut because every site where specific
DNA–protein interactions occur in the remaining Modules
A and B has been tested for function and none mediate
spatial repression and because a single synthetic copy of the
UI target suffices to produce late expression in gut cells(Yuh et al., 1998, 2001 and previous experiments cited
therein). It follows that the gut-specific location of endo16
expression when under UI control must depend directly and
exclusively on where UI itself is expressed. Therefore, a
consequence of the cis-regulatory model is the prediction
that UI must be confined to the endoderm, and most
particularly, that it will be expressed only in midgut once
that region is specified.
In this work, we present the identity of UI, and test
directly the following specific predictions of the endo16 cis-
regulatory logic model of Yuh et al. (2001):
(i) that the gene encoding the bUIQ transcription factor
which controls definitive endo16 expression in the
postgastrular embryo will be expressed exclusively in
midgut;
(ii) that this gene will be activated only at the beginning
of the hump phase of endo16 expression;
(iii) that this gene will display an accelerated rate of
expression before 60 h to account for the accelerated
rate of accumulation of endo16 transcripts from 60 h
on;
(iv) that if translation of the factor encoded by this gene is
interrupted, it will affect late but not early expression
of endogenous endo16;
(v) that such translation arrest will affect expression of
Module B but not Module A constructs in transgenic
embryos.
Of UI itself, we knew little. The factor was originally
inferred as a specific DNA-binding activity in the course of
a gel shift scan of endo16 cis-regulatory DNA, and its
putative target site in Module B was localized by
oligonucleotide competition (Yuh et al., 1994). The func-
tional significance of the UI target site in Module B was
later confirmed by mutation in gene transfer experiments,
and by use of synthetic target site constructs (Yuh et al.,
2001). These experiments clearly demonstrated the essential
role of this yet unidentified factor. The same site was also
found in the cis-regulatory system of the cyIIa gene, in
which it also mediates control of postgastrular expression in
the gut (Arnone et al., 1998).Materials and methods
Recovery of Brn1/2/4 cDNA
An initial attempt was made to isolate the UI factor from
24 h nuclear extract by affinity purification, using the UI
target site from the CyIIa gene (Arnone et al., 1998). The
peptide obtained from the partially purified DNA-binding
protein, however, turned out to be a component of a
previously cloned transcription factor, SpOct1 (Char et al.,
1993). This protein was clearly not likely to be UI because it
is a maternal factor, which is present at enhanced levels
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genes (Bell et al., 1992; Char et al., 1993), as well as of the
CyIIIa gene (Calzone et al., 1988; Kirchhamer et al., 1996).
By the time the endo16 gene is activated, Oct1 levels are
declining. Furthermore, so far as was known Oct1 is
ubiquitous, and there is no evidence for gut specificity. InFig. 2. Amino acid sequences of Brn1/2/4 and selected other POU domain protei
protein. The conserved DNA-binding domain is boxed. Within this region, the P
pair used for QPCR experiments (also located within the POU domain) is mark
probe is highlighted in green. (B) Comparison of protein sequences. The sequenc
the more distantly related paralogous factor SpOct1 (Char et al., 1993; see
Branchiostoma floridae). The comparison was done using NCBI’s bMultiAlign
highly conserved region (N90%) shown in red begins with the POU domain and
sequences are shown in blue.retrospect it is clear that Oct1 protein rather than Brn1/2/4
protein was recovered by affinity purification because at 24 h
the latter has just begun to be expressed (see below), while
Oct1 remains still relatively prevalent (Char et al., 1993).
However, POU domain factors recognize sites that share
certain features (Gruber et al., 1997), and when genomicns. (A) Sequence of full-length S. purpuratus cDNA clone, and of implied
OU domain in shown in blue and the homeodomain in purple. The primer
ed in red; the primer pair used for preparation of the in situ hybridization
e in (A) is shown aligned with orthologues from different species, and with
Materials and methods); gene names are from Genbank (Amphioxus,
Q (http://prodes.toulouse.inra.fr/multalin/multalin.html; Corpet, 1988). The
ends with the homeodomain (cf. A). Amino acids present in N50% of the
Fig. 2 (continued).
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the Human Genome Sequence Center, Baylor University
Medical School; NCBI Trace Repository), we sought other
predicted POU domain factors. There are four such factors
encoded in the S. purpuratus genome including Oct1, as
will be described elsewhere (M. Howard, C. Brown, S.
Materna, L. Chen, R. Cameron and E. Davidson, unpub-
lished data). A second POU domain factor is expressed
maternally and in the early embryo as is Oct1, though at a
very low level according to quantitative PCR (QPCR)
measurements; the third is barely expressed at all in the
embryo, and then only some 12 h later than required for the
known role of UI. The fourth is the subject of this paper.
Initial QPCR studies showed this gene to be quiescent in the
blastula stage embryo, but to be actively transcribed after
gastrulation. cDNAs encoding portions of this mRNA were
isolated from a 40-h embryo RACE library by standard
amplification methods, using conserved POU domain
sequences for design of primers. Full-length cDNA clones
were later obtained from an arrayed 40-h embryo cDNA
library (Cameron et al., 2000).Other methods
Procedures applied in this work for obtaining and
handling embryos, QPCR analysis, use of morpholino-
substituted antisense oligonucleotides, cis-regulatory ana-
lyses, injection of S. purpuratus eggs, and whole mount in
situ hybridization, have all been described in detail: see
Ransick (2004), Revilla-i-Domingo et al. (2004), Oliveri et
al. (2002), Oliveri et al. (2003), Yuh et al. (2002, 2004). To
evaluate the temporal expression profile of brn1/2/4, 1000
embryos at each stage were collected, and RNA was
extracted with the Qiagen bRNeasyQ micro kit. The RNA
was eluted in a final volume of 12 Al. Reverse transcription
was performed using the bTaqManQ kit from Applied
Biosystems. The volume for reverse transcription was
100 Al, and the cDNA solution was diluted to the equivalent
of two embryos per 3 Al for QPCR analysis. Expression
constructs were injected into eggs at a nominal concen-
tration of 1500 molecules per 2 pl solution. 50 to 100
embryos were collected at each desired time point, and
cDNA from two embryos was used per QPCR reaction.
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Features of the predicted sequence of Brn1/2/4
As described in Materials and methods, we had reason to
believe that UI is a POU domain factor, and based on time
of expression, there was only one possible candidate among
the four POU domain factors encoded in the genome. Full-
length cDNAs encoding this putative transcription factor
were obtained, and the DNA and encoded protein sequences
are shown in Fig. 2A. This protein includes both a POU
domain and a homeodomain. The sea urchin cDNA aligns
tightly with several other transcription factors fromFig. 3. Spatial localization of Brn1/2/4 mRNA by whole mount in situ hybridizatio
in the late gastrula (48 h). Embryos were fixed with glutaraldehyde and hybridized
vegetal views. As expected, endo16 is expressed more intensely than is brn1/2/4. (
indicated. Expression of endo16 in the vegetal plate under control of the initial cis
midgut/hindgut constriction has started to form, and expression of both genes is r
terminal gene expression patterns have been set (G, K). These remain the same aamphioxus, zebrafish, Xenopus, and mouse throughout the
POU and homeodomains, as shown in Fig. 2B. However,
outside these DNA-binding domains, these sequences dis-
play only marginal patches of similarity to one other. The
closest orthologues to the putative UI protein were Brn1,
Brn2, and Brn4 from other species (Fig. 2B; and additional
analyses not shown), and the S. purpuratus protein was thus
named bSpBrn1/2/4Q, henceforth Brn1/2/4. Evidence sup-
porting the possible assignment of UI identity to Brn1/2/4 is
the nature of the UI target site in endo16 Module B. This is
a near perfect site for factors of the Brn1/2/4 class of which
that shown in Fig 2 is the only member encoded in the S.
purpuratus genome. The endo16 site is GCAT(GAA)-n. (A–D) Expression of endo16 and brn1/2/4 resolving identically to midgut
with endo16 (A, B) or brn1/2/4 probe (C, D); (A, C) side views and (B, D)
E–L) Expression of endo16 and brn1/2/4 across embryonic development, as
-regulatory system (cf. Fig. 1) precedes that of brn1/2/4 (E, I). At 60 h, the
estricted to midgut (F, J). At 72 h, gut regionalization is complete, and the
s larval development begins (H, L).
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GCAT(N0–3)TAAT (Gruber et al., 1997). As pointed out in
Materials and methods, though some (not all) sites for other
classes of POU domain factor are similar, the expression
profiles for those represented in the S. purpuratus genome
excludes all except Brn1/2/4 from consideration here. Thus,
the importance of the target site comparison is just that it is
consistent with a POU domain-binding motif of the class
found.
Spatial expression of the brn1/2/4 gene
The crucial prediction is that the transcriptional driver of
the later phases of endo16 expression, that is, the factor that
performs the function of UI will be expressed exclusively in
the midgut by the time that endo16 expression is localized to
that domain. This is a direct predicted contrast to the driver
of the earlier phase of endo16 expression, the very
widespread Otx factors (Li et al., 1997; Yuh et al., 2002).
To determine if the spatial expression of the brn1/2/4 geneFig. 4. Transcript accumulation kinetics for endo16 and brn1/2/4. Data were obta
simultaneously in the same RNA preparations (Wang et al., 1995) to obtain absol
single batch of embryos to eliminate any batch to batch variations in growth rate. T
b1–2%, very small compared to variation amongst batches: for example, measure
deviation of 26% at 48 h and 28% at 72 h.conforms to this specific prediction, we carried out a whole
mount in situ hybridization (WMISH) series, using a probe
designed from the sequence as shown in Fig. 2A: remar-
kably, the midgut is exactly where this gene is terminally
expressed. In 42 h prism-stage embryos, seen from the side
and from the vegetal end in Figs. 3A, B, respectively,
endo16 expression is in process of localizing to the midgut
region. The process is almost complete, and detectable
transcript is no longer present at the posterior end of the
archenteron. Figs. 3C, D show that the brn1/2/4 gene is
expressed in an identical spatial pattern in embryos of the
same batch fixed at the same moment, though of course less
intensely (a quantitative comparison is provided in Temporal
expression of brn1/2/4 in relation to that of endo16). Spatial
expression of the two genes is compared over a broader
range of times in Figs. 4E–H (endo16) and Figs. 4I–L
(brn1/2/4). Essentially, they are expressed in the same cells,
except that at 24 h, brn1/2/4 expression is so low as to
barely be visualized, while by the same methods, endo16
expression is easily detectable (early bhumpQ stage; Fig. 1C).ined by QPCR and normalized to the content of Spz12-1 mRNA measured
ute values in molecules per embryo. The data shown were collected from a
he error on the QPCR determinations, which were carried out in triplicate, is
ments of brn1/2/4 molecules/embryo on 6 different batches gave a standard
Fig. 5. Effects of interference with Brn1/2/4 synthesis by MASO treatment
on expression of endo16 and of endo16 cis-regulatory constructs. The
Brn1/2/4 MASO was the anti-sense sequence to the region bGGAGTAAG-
ATGGAGACCGTCATATCQ around the translation start codon. The MASO
sequence was hence bGATATGACGGTCTCCATCTTACTCCQ (synthe-
sized by GeneTools). Observations were made by QPCR on cDNAs
generated from 45-h embryos, normalized by reference to 18S rRNA.
Values obtained from embryos bearing equal amounts of a control MASO
were set at 100% for comparison of different experiments; standard
deviations are indicated. Four separate experiments (i.e., done on different
batches of embryos, except that the control and experimental MASO-
treated eggs of each experiment were of course of the same batch) were
carried out on endogenous endo16, three on the endo16 Module B-CAT
construct, and two on the endo16 Module A construct.
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model listed in Introduction.
Temporal expression of brn1/2/4 in relation to that of
endo16
Absolute measurements of both endo16 and brn1/2/4
transcript content were carried out in the same embryos by
quantitative reverse transcription PCR (QPCR), using inter-
nal standards of known prevalence (Fig. 4). First off, it is to be
noted that these new endo16 expression data, which are of
higher resolution than any previously available, display
precisely the same kinetic form as does the output of the
cis-regulatory constructs reproduced from earlier work in
Fig. 1A (Yuh and Davidson, 1996; Yuh et al., 2001).
Expression of endogenous endo16 begins at about 18 h,
and then enters the hump phase, which ends with the
inflection point at 60 h. Just as does the experimental cis-
regulatory output, after this, the expression profile abruptly
transits into a phase of rapid transcript accumulation that is
continuing unabated when the observations terminate at 72 h
(end of embryogenesis proper).
There are two striking features of the brn1/2/4 expression
kinetics. This regulatory gene is activated between 20 and 21
h, though at a low level, just in time to drive expression of the
hump phase of endo16 expression. This confirms prediction
(ii) of the endo16 model listed in Introduction. There are
during this phase about 30 endo16 expressing cells (early
mesenchyme blastula vegetal plate and then veg2 endoder-
mal torus; Ransick et al., 1993), and so there are during the
hump phase only a few molecules of brn1/2/4 transcript per
cell (Fig. 4). But a few is enough: the average rate of
translation in these embryos is two molecules/min-mRNA
(reviewed by Davidson, 1976), so at the steady state level of
brn1/2/4 mRNA measured, in the 10-h to maximum hump
phase there could have accumulated N1.2 105 molecules of
Brn1/2/4 protein/embryo (i.e., given about 100 molecules of
mRNA per embryo over the period 21–24 h; Fig. 4), or 2–4
103/cell, typically enough to ensure a functional level of site
occupancy (cf. Bolouri and Davidson, 2003).
Just before 30 h, there begins a dramatic climb in the
number of molecules of brn1/2/4 transcript per embryo.
There is no significant cell division in the gut during this
period of gastrular invagination (Hardin and Cheng, 1986).
This kinetic phase terminates at 60 h, just when the terminal
phase of endo16 transcript accumulation begins. Qualita-
tively, these relative kinetic relations fulfill prediction (iii) of
the endo16 model listed in Introduction that there should be
an accelerated rate of driver expression preceding the
accelerated N60 h rate of endo16 transcriptional activity.
We show below that beyond this, the data provide additional
insights into the relation between the driver gene and the
target gene. But this is to put the cart before the horse: it is
first required to demonstrate that Brn1/2/4 indeed does serve
as the driver of late endo16 expression, and in particular of
its cis-regulatory Module B.Effects of brn1/2/4 MASO on endo16 and endo16
expression constructs
The predictions are that if Brn1/2/4 translation is blocked
by treatment with a morpholino-substituted antisense
oligonucleotide (MASO), then late endo16 expression will
be severely affected; and that this treatment will greatly
depress expression of endo16 Module B expression cons-
tructs, but not of Module A expression constructs. The
MASO is a highly sequence-specific reagent and would be
most unlikely to produce these predicted effects unless it
targets the factor that plays the role of UI. These predictions
were tested, and as shown in Fig. 5, demonstrated to be
correct. To obtain these measurements, either endo16
mRNA or CAT reporter mRNA levels were assessed by
C.-H. Yuh et al. / Developmental Biology 281 (2005) 286–298294QPCR in embryos bearing the Brn1/2/4 MASO or a control
MASO (for the specific phenotypic effects of this MASO
see below). The observations were made at 45 h, soon after
the brn1/2/4 gene has entered into its final, midgut-specific
phase of expression. No effects on expression of endo16
were seen in MASO-treated embryos collected at stages
before the brn1/2/4 gene is activated (not shown). Con-
veniently, the magnitudes of the effects measured on the
endogenous endo16 gene and the endo16 Module B
expression construct are very similar at 45 h: this is just
as it should be, since at this period almost all endo16
activity is due to Module B drivers (Fig. 1D, data from Yuh
et al., 2001; the residual activity in the Brn1/2/4 MASO
samples is likely due to the activity of the minor driver of
Module B, CB2). In any case, it is clear that endogenous
Brn1/2/4 is required for normal endo16 expression in vivo,
and that the target site sequences, as expected, are in
Module B and not Module A.
Quantitative aspects of gene expression
In that direct functional evidence as well as structural and
expression data demonstrate the identity of the UI of the
endo16 model with Brn1/2/4, we can now regard these as
target and driver genes, and further consider the time course
measurements in Fig. 5. The relevant late phase data are
replotted in Fig. 6, together with a least squares analysis of
the kinetic parameters that describe brn1/2/4 gene expres-Fig. 6. brn1/2/4 driver gene-endo16 target gene expression kinetics. Data are replo
result of a least squares fit given the relation [d(brn1/2/4)/dt = ks  kd*t], where k
decay rate for the mRNA (1/min). Results for these parameters are listed in Tablsion once the level of its transcript begins its monotonic rise
(see legend). The increase in brn1/2/4 transcript after the
earliest activation phase, as the fit shows, is adequately
represented by a single mRNA synthesis and turnover rate.
That is, once this rate of productive transcription is esta-
blished, the measured mRNA accumulation curve depends
in addition only on the mRNA turnover rate and the number
of genes active. Cell counts indicate that there are about 60
cells in the midgut domain expressing brn1/2/4. Some
interesting parameters that can thereupon be extracted are
listed in Table 1.
First, we see that the brn1/2/4 regulatory gene is being
expressed during this phase at a rate that can only be
described as leisurely, as each gene need be transcribed
productively but once or twice an hour. Significant accu-
mulation of the mRNA nonetheless proceeds steadily
because of the low mRNA turnover rate, which is 3–5
times slower than the default rate for typical sea urchin
embryo mRNAs (reviewed by Davidson, 1986). By the time
about three half-lives have elapsed from the beginning of
this phase of brn1/2/4 expression (72 h) and the transcript
level appears to be reaching steady state, the number of
mRNAs per expressing cell, about 40, is perfectly typical
for an active transcription factor mRNA in the sea urchin
embryo (see data compilation in Bolouri and Davidson,
2002). Though modest, this number will support the
synthesis of a very appreciable amount of Brn1/2/4 factor,
~5000 molecules/cell-h. We do not know the turnover ratetted from Fig. 4. The curve shown for the brn1/2/4 accumulation data is the
s is the rate of synthesis of brn1/2/4 transcript (molecules/min) and kd is the
e 1 (converted into h; half-life is ln2/kd).
Table 1
Endo16 and Brn1/2/4 synthesis rates
Synthesis rate brn1/2/4 mRNA, N30 h: 127 molc./embryo-h; (~2/cell-h)
Half-life brn1/2/4 mRNA, N30 h: 13.9 h
Steady state brn1/2/4 mRNA, N60 h: 2550/embryo; (~40/cell)
Steady state synthesis Brn1/2/4 Factor, >60 h: 3105/embryo-hr;
(~5000/cell-h)
Synthesis rate endo16 mRNA (60–72 h): 2780 molc./embryo-h;
(~45/cell-h)
Synthesis rate Endo16 Protein (72 h): 34,260 molc./min-embryo;
(~1140/cell-min)
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of only one to few hours for its concentration to soon exceed
that required of most transcription factors to achieve target
site occupancy (Bolouri and Davidson, op. cit.).
Relative to all these values for the Brn1/2/4 driver, during
its late phase of definitive expression, the endo16 target
gene is literally roaring along. The absolute number of
transcripts at 72 h exceeds 34,000 per embryo, over 13-fold
the level of driver mRNA at this time. In Fig. 5, we saw that
the initiation of this phase of endo16 expression occurs as
the level of brn1/2/4 mRNA approaches its maximum (i.e.,
within the time scale of embryogenesis; it could well go
higher after feeding begins). It is interesting to consider the
rate of endo16 gene expression in the period 60–72 h (Table
1), when the driver mRNA if not the factor concentration is
close to steady state: even now, this gene only produces
about 45 molecules of mRNA per cell-h, or one molecule
per 2.7 min-gene. This is only 5–10% of the maximum rate
of gene expression of which these cells are capable
(reviewed by Davidson, 1986). Nonetheless, it will sufficeFig. 7. Phenotypes of Brn1/2/4 MASO embryos. The MASO (see legend of Fig. 5
45 h after fertilization. (A, B) Normal morphology of standard control MASO em
midgut/hindgut constrictions are just becoming visible. (C, D) Brn1/2/4 MASO phe
is thin and straight, lacking any sign of partition constrictions. (E, F) Severe reta
Only the foregut appears to have invaginated.to churn out a lot of Endo16 protein, N1000 molecules per
cell-min. The comparison illustrates dramatically how
logistically powerful the driver-target gene cascade is: in
essence, a controlled trickle of regulatory gene transcript
ends up generating the intense expression of a cell type-
specific differentiation gene. It is in this light that the
internal amplification system of the endo16 cis-regulatory
system should be seen (Yuh et al., 2001; Fig. 1). This can
now be appreciated to be an essential part of the late phase
transcriptional regulatory apparatus that transduces the
modest Brn1/2/4 input into a significant level of expression.
The brn1/2/4 gene and the later endoderm gene regulatory
network (GRN)
The brn1/2/4 gene provides an entry into the gastrular and
immediately postgastrular endoderm GRN, extending
beyond the presently available GRN analysis, which termi-
nates in the 24–30 h late blastula–earliest gastrula period
(Davidson et al., 2002a,b; Oliveri and Davidson, 2004). The
following evidence, while in no way allowing a visualization
of the overall GRN architecture, clearly places brn1/2/4 in an
internal position in that part of the GRN which controls
regional midgut specification. That is to say, this gene is
neither at the top of the series of events which lead to midgut
specification, nor at the very periphery of the network.
Since it directly controls the differentiation gene endo16,
it could be that the general and exclusive function of brn1/2/
4 is regulation of a battery of such genes. However, the
interesting MASO phenotype shown in Figs. 7C, D
indicates that embryos in which this factor is unavailablefor sequence) was used at 150 AM for injection. All embryos shown are at
bryos. Tripartition of the gut has begun and the forming foregut/midgut and
notype seen in half the embryos at this MASO dose: bpencilQ gut phenotype
rdation of gut formation observed in other half of MASO-treated embryos.
Fig. 8. Some initial GRN relations for the 30- to 45-h midgut. The diagram
is derived from the perturbation data of Table 2, plus expression data (see
Davidson et al., 2002a,b for symbolism and significance of this mode of
portrayal of the GRN). Of these data, the relations of krox, gatae, otx, foxa,
and bra have all been demonstrated earlier (Davidson et al., 2002a,b;
Oliveri and Davidson, 2004). Present measurements merely either
reproduce the prior measurements to ensure that the MASOs are functional
(b30 h), and then extend these known relationships further forward in time.
All relations upstream and downstream of the brn1/2/4 gene are new.
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present the constrictions at either end of the future midgut
that will demarcate this domain from the foregut and
hindgut. Experience shows, as logic of course predicts, that
such failures of morphogenesis usually imply interference
with spatial transcriptional regulatory processes, the effects
of which often include failure of localized intercellular
signaling. The brn1/2/4 gene therefore may not act only as a
controller of differentiation genes like endo16, but also of
other regulatory and/or signaling genes. Support for this
inference is discussed in the following, though largely it
remains for future work to confirm. A more severe, but less
informative, Brn1/2/4 MASO phenotype is also seen (Figs.
7E, F), in which gastrular invagination of the gut is
completely arrested about halfway through.
Some GRN interrelationships have been revealed by an
initial tier of perturbation experiments involving known
endoderm genes. QPCR data are listed in Table 2, and a
summary of the region of the putative network that is thus
implied is shown in Fig. 8. Here we see, among other things,
that the h1/2Otx factor (Li et al., 1997; Yuh et al., 2002,
2004) is at the top of this portion of the midgut GRN. As we
have previously shown, there is a direct feedback loop
encoded at the cis-regulatory level operating between the
b1/2otx and the gatae genes, the latter of which then
controls many other endodermal genes (Davidson et al.,
2002a,b; Yuh et al., 2004; P-y Lee and Davidson,
unpublished data). But as Table 2 demonstrates, h1/2Otx
also appears to be a driver of the brn1/2/4 gene in the 45-h
midgut. The brn1/2/4 gene is in addition upstream of, and
may directly control, several other regulatory genes at this
time and place: these include foxa, evenskipped, and the
late krox transcription unit, but not gatae, the early krox
transcription unit, or the b1/2otx gene itself. Fig. 8 thus
shows that both the b1/2otx and the brn1/2/4 genes operate
at multiple levels of the GRN. Discovery of the brn1/2/4
gene therefore has not only illuminated the regulation ofTable 2
QPCR perturbation data for the later endoderm GRN
Genes Perturbation 17–18 h
otxb1/2 Brn1/2/4 MASO 1.1 (NS)
brn1/2/4 Brn1/2/4 MASO 0.25 (NS)
eve Brn1/2/4 MASO
foxa Brn1/2/4 MASO
krox(late) Brn1/2/4 MASO
hox11/13b Brn1/2/4 MASO
gatae Brn1/2/4 MASO
brn1/2/4 Gatae MASO 0.5 (NS)
bra Gatae MASO 1.6
endo16 Gatae MASO 2.6
brn1/2/4 Otxh1/2 MASO
ModB-CAT Otxh1/2 MASO
Data shown are differences in QPCR threshold cycle number between embryo
normalization to an internal standard measured simultaneously by the same method
the table for that experiment (see Davidson et al., 2002a,b; Oliveri et al., 2002).endo16, but also has led us to an opening view of the
GRN for specification and differentiation of the midgut.Discussion
Five specific predictions of the endo16 model satisfied
In Introduction, we listed five predictions specifying
how, when, and where the factor providing the UI input of
the endo16 model would be expressed, and what would be
the effects of interrupting its expression on transcription of
endogenous endo16 and of endo16 constructs. The brn1/2/4
experiments presented in this paper show each of these
predictions to be satisfied.
In brief, we have learned the following. After the initial
phase of endo16 activation, when spatial control depends on24–30 h 42–48 h
0.49/0.0 (NS) 1.9/0.8 (NS)
0.13 (NS) 0.2/1.6 (NS)
5.7/1.5
4.4/1.5/3.7
4.4/
0.7 (NS)
0.9 (NS)
0.3/0.0 (NS)
2.8
2.3
0.0/ (NS) 1.7/1.2/2.5/1.7/1.4
0.3 (NS)
s bearing indicated MASOs and embryos bearing control MASOs, after
(here rRNA). Thus, fold effect is the value 1.95 taken to the power given in
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Brn1/2/4 provides the input that determines the spatial
domain of endo16 expression. At the earliest time, it can be
detected byWMISH, Brn1/2/4 is expressed specifically in the
midgut plus hindgut, then soon after in the midgut only, just
as is endo16 (prediction (i); Fig. 3 of this paper). The cis-
regulatory logic model by which the kinetic measurements of
Yuh et al. (1998, 2001) were resolved requires that the hump
phase of endo16 expression (~24–60 h) be driven by Module
B inputs, particularly by what we now know to be the Brn1/2/
4 input (Fig. 1C). Indeed, we show that the gene encoding
Brn1/2/4 is activated at about 22 h. This is about 4 h after
endogenous endo16 transcripts first begin to accumulate,
according to the high-resolution QPCR measurements of
Fig. 4, again just as expected (prediction (ii)). A brn1/2/4
synthesis rate is established by a few hours later which, given
the low transcript turnover rate (Table 1), suffices to cause a
gradual but significant accumulation of the mRNA over the
next day. As the highest level is approached, about 60 h, the
terminal high rate phase of endo16 gene expression is
triggered. Thus, the kinetic analysis of Fig. 6 and Table 1 of
this paper substantiates the driver-target gene relation implicit
in the endo16 model (prediction (iii)). The causality of this
relation is shown by the brn1/2/4 MASO effects on
endogenous endo16 expression (prediction (iv)); and the
cis-regulatory locus of the interaction by the destructive
effect of the MASO on the expression of Module B but not
Module A (prediction (v); Fig. 5 of this paper). The brn1/2/4
data thus support the arguments of the endo16 model in
mechanistic detail.
This model was based exclusively on the results of an
extensive cis-regulatory logic analysis (Yuh et al., 2001). As
indeed must be the case, because it encodes the source
functional design, we see that the genomic cis-regulatory
logic code enables accurate prediction of many input/output
functions in advance of biochemical knowledge of the
behavior of the players.
The endo16 and brn1/2/4 genes, and the developmental
process
The shift from spatial control by the generally present Otx
factor plus spatial repressors to control by the tissue-specific
Brn1/2/4 factor is one of the revealing features of the endo16
regulatory system (Yuh et al., 2001; Fig. 1). This kind of
change often distinguishes early from more advanced spatial
specification processes. Essentially, from the vantage point of
the endo16 cis-regulatory system, the change consists of
bkicking upstairsQ, the information processing functions that
control spatial expression. That is, control is now removed to
the level of the cis-regulatory system that determines
expression of the brn1/2/4 gene. This gene functions in the
postgastrular midgut regionalization process, and as the
WMISH displays of Fig. 3 illustrate, brn1/2/4 comes to be
expressed with exquisite accuracy in the cells of the future
and definitive midgut. Its own control systemwill constitute anode of the later endoderm GRN, the regulatory architecture
of which will specify its pattern of expression. But the shift in
level of control cannot occur until there is an bupstairsQ, so to
speak. Thus, the existence of the early, that is, prior, control
system implies that there is a necessary early functional role
for endo16 expression. Perhaps, it is only transcriptional
activity that must be established in order for the early Brn1/2/
4 input to execute its activation function when it appears
some hours later, but perhaps also the Endo16 protein has
some particular function in the vegetal plate of the blastula
and early gastrula, other than what it does when secreted into
the lumen of the developedmidgut. Just as an example, a pure
speculation, the Endo16 glycoprotein might affect cell
surface properties so as to facilitate the movement of
endoderm cells with respect to one another. It is tempting in
any case to guess that the endo16 expression kinetics directly
reveal the functional phases of Endo16 use: the kinetic hump
represents the end blastula-to-gastrulation process phase, and
the late kinetic rise the preparation for feeding.
The rates that characterize the Brn1/2/4 driver-endo16
target gene relation (Table 2) can be viewed in this light.
Between the initial transcriptional specification of the midgut
and the onset of feeding almost 2 days elapse. During this
time, the gut parts must complete their differentiation, and at
the end, the last major morphological event of embryo-
genesis, the larval mouth must form. The terminal rate of
Endo16 protein synthesis is N1000 molecules/cell-min
(Table 2), and once this rate is installed, the food processing
apparatus is clearly getting ready for business. But this cannot
happen too soon, and so the very gradual rate of accumulation
of brn1/2/4 transcripts serves as a delay device. It can work
this way because the endo16 cis-regulatory apparatus
apparently has the feature that it requires the terminal steady
state level of brn1/2/4 driver mRNA in order to turn on
expression at the rate established after 60 h. This is one of the
few examples we have encountered in which maximal
regulatory transcript level controls are decisive (cf. Bolouri
and Davidson, 2002), and significantly, it pertains to the end,
and not the process, of development.Acknowledgments
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